Question 1

Does Barclays own CLDX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 15,087 shares of CLDX (Celldex Therapeutics), worth $561,388.

Question 2

How many shares of CLDX does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 15,087 shares of CLDX (Celldex Therapeutics).

Question 3

What is Barclays' CLDX position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' CLDX position is worth $561,388.

Question 4

Is Barclays buying or selling CLDX?

Accepted Answer

In Q2 2026, Barclays increased its CLDX position by 1,112 shares (+8.0%).

Question 5

When did Barclays first buy CLDX?

Accepted Answer

Barclays first reported CLDX in its Q1 2019 13F and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	15,087	+8.0%	$561,388	0.0%	$37.21	26
2026-Q1	Decreased	13,975	-94.2%	$443,288	0.0%	$31.72	0
2025-Q4	Decreased	240,594	-1.7%	$6.5M	0.0%	$27.16	0
2025-Q3	Decreased	244,825	-6.8%	$6.3M	0.0%	$25.87	0
2025-Q2	Increased	262,725	+125.4%	$5.3M	0.0%	$20.35	44
2025-Q1	Decreased	116,566	-18.4%	$2.1M	0.0%	$18.15	0
2024-Q4	Increased	142,914	+9.6%	$3.6M	0.0%	$25.27	29
2024-Q3	Increased	130,381	+140.7%	$4.4M	0.0%	$33.99	43